(IFRS unaudited provisional data)
Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) announces an operating revenue of 7.7 million euros for the year 2009. Turnover for the year amounted 3.3 million euros, including 0.5 million euros in the fourth quarter ended December 31, 2009.
| PR in english | 42.65 KB |
| CP en français | 32.81 KB |